Needle to needle robot‐assisted manufacture of cell therapy products

Needle to needle robot‐assisted manufacture of cell therapy products

Abstract Advanced therapeutic medicinal products (ATMPs) have emerged as novel therapies for untreatable diseases, generating the need for large volumes of high‐quality, clinically‐compliant GMP cells to replace costly, high‐risk and limited scale manual expansion processes. We present the design of...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Jelena Ochs, Mariana P. Hanga, Georgina Shaw, Niamh Duffy, Michael Kulik, Nokilaj Tissin, Daniel Reibert, Ferdinand Biermann, Panagiota Moutsatsou, Shibani Ratnayake, Alvin Nienow, Niels Koenig, Robert Schmitt, Qasim Rafiq, Christopher J. Hewitt, Frank Barry, J. Mary Murphy
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Wiley 2022-09-01
Sarja:Bioengineering & Translational Medicine
Aiheet:
automation: bioreactors
cell therapy
human stem cells
manufacturing
Linkit:https://doi.org/10.1002/btm2.10387

Internet

https://doi.org/10.1002/btm2.10387

Samankaltaisia teoksia